Vaccine development to prevent Staphylococcus aureus surgical-site infections.
Identifieur interne : 000085 ( Main/Exploration ); précédent : 000084; suivant : 000086Vaccine development to prevent Staphylococcus aureus surgical-site infections.
Auteurs : N. Mohamed [États-Unis] ; M Y Wang [États-Unis] ; J-C Le Huec [France] ; U. Liljenqvist [Allemagne] ; I L Scully [États-Unis] ; J. Baber [Australie] ; E. Begier [États-Unis] ; K U Jansen [États-Unis] ; A. Gurtman [États-Unis] ; A S Anderson [États-Unis]Source :
- The British journal of surgery [ 1365-2168 ] ; 2017.
Descripteurs français
- KwdFr :
- Antibioprophylaxie, Essais cliniques comme sujet, Humains, Infection de plaie opératoire (), Infection de plaie opératoire (microbiologie), Infections à staphylocoques (), Lutte contre l'infection (), Résistance bactérienne aux médicaments, Staphylococcus aureus (pathogénicité), Vaccins antistaphylococciques (usage thérapeutique).
- MESH :
- microbiologie : Infection de plaie opératoire.
- pathogénicité : Staphylococcus aureus.
- usage thérapeutique : Vaccins antistaphylococciques.
- Antibioprophylaxie, Essais cliniques comme sujet, Humains, Infection de plaie opératoire, Infections à staphylocoques, Lutte contre l'infection, Résistance bactérienne aux médicaments.
English descriptors
- KwdEn :
- Antibiotic Prophylaxis, Clinical Trials as Topic, Drug Resistance, Bacterial, Humans, Infection Control (methods), Staphylococcal Infections (prevention & control), Staphylococcal Vaccines (therapeutic use), Staphylococcus aureus (pathogenicity), Surgical Wound Infection (microbiology), Surgical Wound Infection (prevention & control).
- MESH :
- chemical , therapeutic use : Staphylococcal Vaccines.
- methods : Infection Control.
- microbiology : Surgical Wound Infection.
- pathogenicity : Staphylococcus aureus.
- prevention & control : Staphylococcal Infections, Surgical Wound Infection.
- Antibiotic Prophylaxis, Clinical Trials as Topic, Drug Resistance, Bacterial, Humans.
Abstract
Staphylococcus aureus surgical-site infections (SSIs) are a major cause of poor health outcomes, including mortality, across surgical specialties. Despite current advances as a result of preventive interventions, the disease burden of S. aureus SSI remains high, and increasing antibiotic resistance continues to be a concern. Prophylactic S. aureus vaccines may represent an opportunity to prevent SSI.
DOI: 10.1002/bjs.10454
PubMed: 28121039
Affiliations:
- Allemagne, Australie, France, États-Unis
- Aquitaine, District de Münster, Floride, Nouvelle-Aquitaine, Rhénanie-du-Nord-Westphalie, État de New York
- Bordeaux, Münster
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001317
- to stream PubMed, to step Curation: 001295
- to stream PubMed, to step Checkpoint: 001295
- to stream Ncbi, to step Merge: 004219
- to stream Ncbi, to step Curation: 004219
- to stream Ncbi, to step Checkpoint: 004219
- to stream Main, to step Merge: 000080
- to stream Main, to step Curation: 000085
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Vaccine development to prevent Staphylococcus aureus surgical-site infections.</title><author><name sortKey="Mohamed, N" sort="Mohamed, N" uniqKey="Mohamed N" first="N" last="Mohamed">N. Mohamed</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Vaccine Research and Development, Pearl River, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pfizer Vaccine Research and Development, Pearl River, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Wang, M Y" sort="Wang, M Y" uniqKey="Wang M" first="M Y" last="Wang">M Y Wang</name><affiliation wicri:level="2"><nlm:affiliation>Departments of Neurological Surgery and Rehabilitation Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Departments of Neurological Surgery and Rehabilitation Medicine, University of Miami Miller School of Medicine, Miami, Florida</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Le Huec, J C" sort="Le Huec, J C" uniqKey="Le Huec J" first="J-C" last="Le Huec">J-C Le Huec</name><affiliation wicri:level="3"><nlm:affiliation>Spine Unit 2, Surgical Research Laboratory, Bordeaux University Hospital, Bordeaux, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Spine Unit 2, Surgical Research Laboratory, Bordeaux University Hospital, Bordeaux</wicri:regionArea><placeName><region type="region">Nouvelle-Aquitaine</region><region type="old region">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="Liljenqvist, U" sort="Liljenqvist, U" uniqKey="Liljenqvist U" first="U" last="Liljenqvist">U. Liljenqvist</name><affiliation wicri:level="3"><nlm:affiliation>Department of Spine Surgery, St Franziskus Hospital Muenster, Münster, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Spine Surgery, St Franziskus Hospital Muenster, Münster</wicri:regionArea><placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region><region type="district" nuts="2">District de Münster</region><settlement type="city">Münster</settlement></placeName></affiliation></author><author><name sortKey="Scully, I L" sort="Scully, I L" uniqKey="Scully I" first="I L" last="Scully">I L Scully</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Vaccine Research and Development, Pearl River, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pfizer Vaccine Research and Development, Pearl River, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Baber, J" sort="Baber, J" uniqKey="Baber J" first="J" last="Baber">J. Baber</name><affiliation wicri:level="1"><nlm:affiliation>Pfizer Vaccine Clinical Research and Development, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Pfizer Vaccine Clinical Research and Development, Sydney, New South Wales</wicri:regionArea><wicri:noRegion>New South Wales</wicri:noRegion></affiliation></author><author><name sortKey="Begier, E" sort="Begier, E" uniqKey="Begier E" first="E" last="Begier">E. Begier</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Vaccine Clinical Research and Development, Pearl River, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pfizer Vaccine Clinical Research and Development, Pearl River, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Jansen, K U" sort="Jansen, K U" uniqKey="Jansen K" first="K U" last="Jansen">K U Jansen</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Vaccine Research and Development, Pearl River, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pfizer Vaccine Research and Development, Pearl River, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Gurtman, A" sort="Gurtman, A" uniqKey="Gurtman A" first="A" last="Gurtman">A. Gurtman</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Vaccine Clinical Research and Development, Pearl River, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pfizer Vaccine Clinical Research and Development, Pearl River, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Anderson, A S" sort="Anderson, A S" uniqKey="Anderson A" first="A S" last="Anderson">A S Anderson</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Vaccine Research and Development, Pearl River, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pfizer Vaccine Research and Development, Pearl River, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28121039</idno><idno type="pmid">28121039</idno><idno type="doi">10.1002/bjs.10454</idno><idno type="wicri:Area/PubMed/Corpus">001317</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001317</idno><idno type="wicri:Area/PubMed/Curation">001295</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001295</idno><idno type="wicri:Area/PubMed/Checkpoint">001295</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001295</idno><idno type="wicri:Area/Ncbi/Merge">004219</idno><idno type="wicri:Area/Ncbi/Curation">004219</idno><idno type="wicri:Area/Ncbi/Checkpoint">004219</idno><idno type="wicri:Area/Main/Merge">000080</idno><idno type="wicri:Area/Main/Curation">000085</idno><idno type="wicri:Area/Main/Exploration">000085</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Vaccine development to prevent Staphylococcus aureus surgical-site infections.</title><author><name sortKey="Mohamed, N" sort="Mohamed, N" uniqKey="Mohamed N" first="N" last="Mohamed">N. Mohamed</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Vaccine Research and Development, Pearl River, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pfizer Vaccine Research and Development, Pearl River, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Wang, M Y" sort="Wang, M Y" uniqKey="Wang M" first="M Y" last="Wang">M Y Wang</name><affiliation wicri:level="2"><nlm:affiliation>Departments of Neurological Surgery and Rehabilitation Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Departments of Neurological Surgery and Rehabilitation Medicine, University of Miami Miller School of Medicine, Miami, Florida</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Le Huec, J C" sort="Le Huec, J C" uniqKey="Le Huec J" first="J-C" last="Le Huec">J-C Le Huec</name><affiliation wicri:level="3"><nlm:affiliation>Spine Unit 2, Surgical Research Laboratory, Bordeaux University Hospital, Bordeaux, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Spine Unit 2, Surgical Research Laboratory, Bordeaux University Hospital, Bordeaux</wicri:regionArea><placeName><region type="region">Nouvelle-Aquitaine</region><region type="old region">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="Liljenqvist, U" sort="Liljenqvist, U" uniqKey="Liljenqvist U" first="U" last="Liljenqvist">U. Liljenqvist</name><affiliation wicri:level="3"><nlm:affiliation>Department of Spine Surgery, St Franziskus Hospital Muenster, Münster, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Spine Surgery, St Franziskus Hospital Muenster, Münster</wicri:regionArea><placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region><region type="district" nuts="2">District de Münster</region><settlement type="city">Münster</settlement></placeName></affiliation></author><author><name sortKey="Scully, I L" sort="Scully, I L" uniqKey="Scully I" first="I L" last="Scully">I L Scully</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Vaccine Research and Development, Pearl River, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pfizer Vaccine Research and Development, Pearl River, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Baber, J" sort="Baber, J" uniqKey="Baber J" first="J" last="Baber">J. Baber</name><affiliation wicri:level="1"><nlm:affiliation>Pfizer Vaccine Clinical Research and Development, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Pfizer Vaccine Clinical Research and Development, Sydney, New South Wales</wicri:regionArea><wicri:noRegion>New South Wales</wicri:noRegion></affiliation></author><author><name sortKey="Begier, E" sort="Begier, E" uniqKey="Begier E" first="E" last="Begier">E. Begier</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Vaccine Clinical Research and Development, Pearl River, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pfizer Vaccine Clinical Research and Development, Pearl River, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Jansen, K U" sort="Jansen, K U" uniqKey="Jansen K" first="K U" last="Jansen">K U Jansen</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Vaccine Research and Development, Pearl River, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pfizer Vaccine Research and Development, Pearl River, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Gurtman, A" sort="Gurtman, A" uniqKey="Gurtman A" first="A" last="Gurtman">A. Gurtman</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Vaccine Clinical Research and Development, Pearl River, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pfizer Vaccine Clinical Research and Development, Pearl River, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Anderson, A S" sort="Anderson, A S" uniqKey="Anderson A" first="A S" last="Anderson">A S Anderson</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Vaccine Research and Development, Pearl River, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pfizer Vaccine Research and Development, Pearl River, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author></analytic><series><title level="j">The British journal of surgery</title><idno type="eISSN">1365-2168</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibiotic Prophylaxis</term><term>Clinical Trials as Topic</term><term>Drug Resistance, Bacterial</term><term>Humans</term><term>Infection Control (methods)</term><term>Staphylococcal Infections (prevention & control)</term><term>Staphylococcal Vaccines (therapeutic use)</term><term>Staphylococcus aureus (pathogenicity)</term><term>Surgical Wound Infection (microbiology)</term><term>Surgical Wound Infection (prevention & control)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antibioprophylaxie</term><term>Essais cliniques comme sujet</term><term>Humains</term><term>Infection de plaie opératoire ()</term><term>Infection de plaie opératoire (microbiologie)</term><term>Infections à staphylocoques ()</term><term>Lutte contre l'infection ()</term><term>Résistance bactérienne aux médicaments</term><term>Staphylococcus aureus (pathogénicité)</term><term>Vaccins antistaphylococciques (usage thérapeutique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Staphylococcal Vaccines</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Infection Control</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Infection de plaie opératoire</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Surgical Wound Infection</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Staphylococcus aureus</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Staphylococcus aureus</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Staphylococcal Infections</term><term>Surgical Wound Infection</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Vaccins antistaphylococciques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Antibiotic Prophylaxis</term><term>Clinical Trials as Topic</term><term>Drug Resistance, Bacterial</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Antibioprophylaxie</term><term>Essais cliniques comme sujet</term><term>Humains</term><term>Infection de plaie opératoire</term><term>Infections à staphylocoques</term><term>Lutte contre l'infection</term><term>Résistance bactérienne aux médicaments</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Staphylococcus aureus surgical-site infections (SSIs) are a major cause of poor health outcomes, including mortality, across surgical specialties. Despite current advances as a result of preventive interventions, the disease burden of S. aureus SSI remains high, and increasing antibiotic resistance continues to be a concern. Prophylactic S. aureus vaccines may represent an opportunity to prevent SSI.</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>Australie</li><li>France</li><li>États-Unis</li></country><region><li>Aquitaine</li><li>District de Münster</li><li>Floride</li><li>Nouvelle-Aquitaine</li><li>Rhénanie-du-Nord-Westphalie</li><li>État de New York</li></region><settlement><li>Bordeaux</li><li>Münster</li></settlement></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Mohamed, N" sort="Mohamed, N" uniqKey="Mohamed N" first="N" last="Mohamed">N. Mohamed</name></region><name sortKey="Anderson, A S" sort="Anderson, A S" uniqKey="Anderson A" first="A S" last="Anderson">A S Anderson</name><name sortKey="Begier, E" sort="Begier, E" uniqKey="Begier E" first="E" last="Begier">E. Begier</name><name sortKey="Gurtman, A" sort="Gurtman, A" uniqKey="Gurtman A" first="A" last="Gurtman">A. Gurtman</name><name sortKey="Jansen, K U" sort="Jansen, K U" uniqKey="Jansen K" first="K U" last="Jansen">K U Jansen</name><name sortKey="Scully, I L" sort="Scully, I L" uniqKey="Scully I" first="I L" last="Scully">I L Scully</name><name sortKey="Wang, M Y" sort="Wang, M Y" uniqKey="Wang M" first="M Y" last="Wang">M Y Wang</name></country><country name="France"><region name="Nouvelle-Aquitaine"><name sortKey="Le Huec, J C" sort="Le Huec, J C" uniqKey="Le Huec J" first="J-C" last="Le Huec">J-C Le Huec</name></region></country><country name="Allemagne"><region name="Rhénanie-du-Nord-Westphalie"><name sortKey="Liljenqvist, U" sort="Liljenqvist, U" uniqKey="Liljenqvist U" first="U" last="Liljenqvist">U. Liljenqvist</name></region></country><country name="Australie"><noRegion><name sortKey="Baber, J" sort="Baber, J" uniqKey="Baber J" first="J" last="Baber">J. Baber</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000085 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000085 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:28121039
|texte= Vaccine development to prevent Staphylococcus aureus surgical-site infections.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28121039" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |